| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 05/10/2007 | US20070105859 4-Phenylamino-benzaldoxime derivatives and uses thereof as mitogen-activated protein kinase kinase (mek) inhibitors |
| 05/10/2007 | US20070105846 Phenylene derivative having tetrazole ring or thiazolidinedione ring |
| 05/10/2007 | US20070105191 Capable of inducing chondrocyte proliferation; Chinese Hamster Ovary, an Escheria coli or a yeast host cell with an expression vector |
| 05/10/2007 | US20070104759 Sustained release inserts; mixture of thermoplastic polyester, solvent and leuprolide acetate; prostate cancer |
| 05/10/2007 | CA2628014A1 Ortho-substituted aniline derivative and antioxidant drug |
| 05/09/2007 | EP1783221A1 Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor |
| 05/09/2007 | EP1782830A1 Preventive and/or remedy for lower urinary tract diseases containing ep4 agonist |
| 05/09/2007 | EP1781375A2 Mixture of catechins or polyphenols extracted from chinese green tea or other vegetables for the prevention of prostate cancer and for the treatment of prostate hypertrophy (bph) |
| 05/09/2007 | EP1781281A1 Compositions for urinary dysfunction and edema containing decursin and/or decursinol angelate, or angelica extract containing decursin and /or decursinol angelate |
| 05/09/2007 | EP1573031A4 Androgen regulated nucleic acid molecules and encoded proteins |
| 05/09/2007 | EP1551369A4 Combination therapy for treatment of fibrotic disorders |
| 05/09/2007 | EP1191931B1 1-(4-sulfamylphenyl)-3-trifluoromethyl-5-aryl-2-pyrazolines as inhibitors of cyclooxygenase-2 |
| 05/09/2007 | CN1960977A Quinazoline derivative |
| 05/09/2007 | CN1958611A Mucin antibody in sera, and usage |
| 05/09/2007 | CN1958065A Pidotimod capsule, and preparation |
| 05/09/2007 | CN1958055A Chinese traditional medicine for treating increased urinary frequency, enuresis, and preparation method |
| 05/09/2007 | CN1958028A Preparation of Chinese traditional medicine for treating hyperplasia of prostate |
| 05/09/2007 | CN1314674C Use of 2-amino-thiazoline derivatives as inhibitors of inducible NO-synthase |
| 05/09/2007 | CN1314439C Chinese medicinal formulation for treating chronic renal insufficiency |
| 05/09/2007 | CN1314412C Chinese medicine for treating acute and chronic nephritis and its prepn |
| 05/09/2007 | CN1314406C Application of montmorillonite in pharmacy |
| 05/09/2007 | CN1314388C Four component tumeric tablet and its preparation method |
| 05/09/2007 | CN1314386C Tripterygium hypoglaucum contained transdermal plaster and its preparation |
| 05/08/2007 | US7214714 for treatment of renal diseases, cerebrovascular diseases and circulatory diseases |
| 05/08/2007 | US7214697 2-Oxo-benzimidazolyl substituted ethanolamine derivatives and their use as β3 agonists |
| 05/08/2007 | US7214690 For therapy of acne, male- pattern baldness, sexual dysfunction, impotence, wasting diseases, hirsutism, hypogonadism, prostatic hyperplasia, osteoporosis, cancer cachexia, and hormone-dependent cancers |
| 05/08/2007 | US7214687 Quinuclidine derivatives and medicinal compositions containing the same |
| 05/08/2007 | US7214677 Benzamide, heteroarylamide and reverse amides |
| 05/08/2007 | US7214512 Genomic mammary Amyloid a sequence |
| 05/08/2007 | US7214495 Screening method |
| 05/08/2007 | CA2275479C Prevention of loss and restoration of bone mass by certain prostaglandin agonists |
| 05/03/2007 | WO2007050732A1 INDAZOLE DERIVATIVES THAT INHIBIT TRPVl RECEPTOR |
| 05/03/2007 | WO2007049798A1 Novel benzoxathiin derivative |
| 05/03/2007 | WO2007049624A1 Preventives/remedies for cancer |
| 05/03/2007 | WO2007049224A1 Novel hexahydro- or octahydro-cyclopenta[c]pyrrole derivatives |
| 05/03/2007 | US20070099985 Heteroaromate OSC inhibitors |
| 05/03/2007 | US20070099953 3(R)-1-Phenethyl-(9[H]-xanthene-9-carbonyloxy)-1-azoniabicyclo[2.2.2] octane quaternary salt with a mono- or polyvalent anion; antimuscarinic agents used to treat chronic obstructive pulmonary disease, chronic bronchitis, bronchial hyperreactivity, asthma, or rhinitis |
| 05/03/2007 | US20070099921 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 05/03/2007 | US20070099899 Heterocyclic dihydropyrimidine compounds |
| 05/03/2007 | US20070099892 Cyanomethyl substituted thiazoliums and imidazoliums and treatments of disorders associated with protein aging |
| 05/03/2007 | US20070098634 method of inhibiting the growth; inhibiting neoplastic cell growth; cancer |
| 05/03/2007 | CA2627139A1 Novel benzoxathiin derivative |
| 05/03/2007 | CA2626593A1 Indazole derivatives that inhibit trpv1 receptor |
| 05/03/2007 | CA2624221A1 Preventives/remedies for cancer |
| 05/02/2007 | EP1780196A2 Pyridine derivatives for use as vanilloid receptor ligands |
| 05/02/2007 | EP1778279A1 Pharmaceutical composition containing botulinum neurotoxin a2 |
| 05/02/2007 | EP1501517B1 Pharmaceutical combination for the treatment of benign prostatic hyperplasia or for the long-term prevention of acute urinary retention |
| 05/02/2007 | EP1370256B1 Novel inhibitors of formation of advanced glycation endproducts (ages) |
| 05/02/2007 | EP1311248B1 Transdermal therapeutic system for treating restless-legs-syndrome |
| 05/02/2007 | EP1261372B1 Method of treating cancer with anti-neurotrophin agents |
| 05/02/2007 | EP1226155B1 18-nor-steroids as selectively active estrogens |
| 05/02/2007 | EP1202734B1 3(5)-ureido-pyrazole derivatives, process for their preparation and their use as antitumor agents |
| 05/02/2007 | CN1956714A Alpha-aminoamide derivatives useful in the treatment of lower urinary tract disorders |
| 05/02/2007 | CN1955192A Protein for promoting erythrocyte growth factor activity and its use |
| 05/02/2007 | CN1954865A Oral liquid for kidney-tonifying and strengthening yang and its preparation method |
| 05/02/2007 | CN1954864A Life-saving pill for acute abdomen |
| 05/02/2007 | CN1313450C Tachykinin receptor antagonists |
| 05/02/2007 | CN1313125C Urinary calculus dissolving solution |
| 05/02/2007 | CN1313096C Asiaticoside use of medicinal preparation for treating and preventing chronic renal failure |
| 05/02/2007 | CN1313079C Traditional Chinese medicine preparation for treating prostatitis and preparation method thereof |
| 05/01/2007 | USRE39608 Substituted benzimidazoles and their use as PARP inhibitors |
| 05/01/2007 | US7211678 Crystal of 2-amino-3-cyano-4-methyl-5-(2-fluorophenyl)pyrrole; treating pollakiuria or urinary incontinence. |
| 05/01/2007 | US7211656 Using the enzymes to make polyunsaturated fatty acids; added to pharmaceutical compositions, nutritional compositions, animal feeds, cosmetics |
| 05/01/2007 | US7211601 Prevention labor contraction; urogenital disorders |
| 05/01/2007 | US7211598 Oxime and/or hydrozone containing nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 05/01/2007 | US7211261 Stable liquid formulations of botulinum toxin |
| 05/01/2007 | CA2320706C 20-hete antagonists and agonists |
| 04/26/2007 | WO2007047430A2 Method of treating acute failure with thrombomodulin variant |
| 04/26/2007 | WO2007047282A1 Treatment of benign prostatic hypertrophy and lower urinary tract symptoms |
| 04/26/2007 | WO2007046392A1 Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof |
| 04/26/2007 | WO2007046004A1 Treatment of the symptoms of bladder irritation |
| 04/26/2007 | WO2007046003A1 Treatment of stress urinary incontinence and mixed urinary incontinence |
| 04/26/2007 | WO2007045184A1 The peptides essence receptor antagonist which 2-site containing proline or crico-amino acid |
| 04/26/2007 | US20070093553 HMB compositions and uses thereof |
| 04/26/2007 | US20070093530 Substituted indolealkanoic acids |
| 04/26/2007 | US20070092918 Detection of the PC-LECTIN protein which correlates to the presence of an androgen-dependent prostate cancer cell; drug target and diagnostic marker for prostate cancer |
| 04/26/2007 | US20070092566 Oral sustained-release tablet |
| 04/26/2007 | US20070092513 Antiproliferative agents; anticancer agents; controlling excessive proliferation or migration of smooth muscle cells by treating said smooth muscle cells with an effective amount of an antagonist of a native ErbB4 receptor |
| 04/26/2007 | CA2626581A1 Treatment of stress urinary incontinence and mixed urinary incontinence |
| 04/26/2007 | CA2626573A1 Treatment of the symptoms of bladder irritation |
| 04/26/2007 | CA2625888A1 Method of treating acute failure with thrombomodulin variant |
| 04/26/2007 | CA2624492A1 Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof |
| 04/25/2007 | EP1777214A2 Novel aryloxy-alkyl-dialkylamines |
| 04/25/2007 | EP1776959A2 Use of HGF for the manufacture of a medicament for treating fibrotic disorders |
| 04/25/2007 | EP1776953A1 Solid oral dosage forms comprising valsartan |
| 04/25/2007 | EP1776137A1 Pharmaceutical composition containing botulinum neurotoxin a2 |
| 04/25/2007 | EP1776118A2 Iron chelators for treating radiocontrast-associated renal dysfunction |
| 04/25/2007 | EP1776108A1 Enoximone formulations and their use in the treatment of pde-iii mediated diseases |
| 04/25/2007 | EP1425042B1 Complement pathway inhibitors binding to c5 and c5a without preventing the formation of c5b |
| 04/25/2007 | EP1401449B1 Tetracyclic compounds as pde5-inhibitors |
| 04/25/2007 | EP1305294B1 Imidazolyl derivatives |
| 04/25/2007 | EP1210948B1 Therapeutc peptide for nervous diseases |
| 04/25/2007 | EP1210425B1 Baff receptor (bcma), an immunoregulatory agent |
| 04/25/2007 | EP1197208B1 Sustained release compositions, process for producing the same and use thereof |
| 04/25/2007 | EP1040101B1 Substituted 2-aryl-4-amino-chinazolines, method for the production and use thereof as medicaments |
| 04/25/2007 | EP0866656B1 Use of n-substituted pyridones as tumor necrosis factor alpha inhibitors |
| 04/25/2007 | CN1953756A Insulin resistance improving agent |
| 04/25/2007 | CN1953752A Treatment of interstitial cystitis with vitamin D compounds |
| 04/25/2007 | CN1951955A Peptide-like endothelin receptor antagonist with proline or cyclic amino acid on 2-postion |
| 04/25/2007 | CN1951939A Novel pyrrole derivatives as pharmaceutical agents |